Home
Explore
Journal Club
Trending
More
synapse
⌘+K
Language
English
English
Respiratory sarcopenia and prehabilitation in thoracic oncology: Diagnostic approaches and clinical implications | Synapse
March 3, 2026
Respiratory sarcopenia and prehabilitation in thoracic oncology: Diagnostic approaches and clinical implications
DD
David Dávila-Dupont
MA
Marisol Arroyo-Hernández
Instituto Nacional de Cancerología
JT
Jenny G. Turcott
See all
Key Points
Respiratory sarcopenia significantly impacts treatment outcomes in thoracic oncology patients, highlighting its importance.
Prehabilitation improves physical fitness and recovery, with evidence suggesting benefits across varied patient profiles.
Observational analysis across various centers indicates the need for enhanced diagnostic approaches to identify respiratory sarcopenia.
The findings suggest prehabilitation could enable better outcomes; however, external validation is necessary.
Mark Helpful
Mark Helpful
Save
Bookmark
Relay
Relay
Mark Helpful
Mark Helpful
Save
Bookmark
Relay
Relay
Cite This Study
Copy
Dávila-Dupont et al. (Sun,) studied this question.
synapsesocial.com/papers/69a76586badf0bb9e87d96b8
https://doi.org/https://doi.org/10.1016/j.lungcan.2026.108949